Cited by 28

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Kidins220 deficiency causes ventriculomegaly via SNX27-retromer-dependent AQP4 degradation

del Puerto, Ana, Pose-Utrilla, Julia, Simón-García, Ana, López-Menéndez, Celia, Jiménez, Antonio J., Porlan, Eva, Pajuelo, Luis S. M., Cano-García, Guillermo, Martí-Prado, Beatriz, Sebastián-Serrano, Álvaro, Sánchez-Carralero, Marina P., Cesca, Fabrizia, Schiavo, Giampietro, Ferrer, Isidro, Fariñas, Isabel, Campanero, Miguel R., Iglesias, Teresa·2021·Molecular Psychiatry

Abstract

Several psychiatric, neurologic and neurodegenerative disorders present increased brain ventricles volume, being hydrocephalus the disease with the major manifestation of ventriculomegaly caused by the accumulation of high amounts of cerebrospinal fluid (CSF). The molecules and pathomechanisms underlying cerebral ventricular enlargement are widely unknown. Kinase D interacting substrate of 220 kDa (KIDINS220) gene has been recently associated with schizophrenia and with a novel syndrome characterized by spastic paraplegia, intellectual disability, nystagmus and obesity (SINO syndrome), diseases frequently occurring with ventriculomegaly. Here we show that Kidins220, a transmembrane protein effector of various key neuronal signalling pathways, is a critical regulator of CSF homeostasis. We observe that both KIDINS220 and the water channel aquaporin-4 (AQP4) are markedly downregulated at the ventricular ependymal lining of idiopathic normal pressure hydrocephalus (iNPH) patients. We also find that Kidins220 deficient mice develop ventriculomegaly accompanied by water dyshomeostasis and loss of AQP4 in the brain ventricular ependymal layer and astrocytes. Kidins220 is a known cargo of the SNX27-retromer, a complex that redirects endocytosed plasma membrane proteins (cargos) back to the cell surface, thus avoiding their targeting to lysosomes for degradation. Mechanistically, we show that AQP4 is a novel cargo of the SNX27-retromer and that Kidins220 deficiency promotes a striking and unexpected downregulation of the SNX27-retromer that results in AQP4 lysosomal degradation. Accordingly, SNX27 silencing decreases AQP4 levels in wild-type astrocytes whereas SNX27 overexpression restores AQP4 content in Kidins220 deficient astrocytes. Together our data suggest that the KIDINS220-SNX27-retromer-AQP4 pathway is involved in human ventriculomegaly and open novel therapeutic perspectives.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41380-021-01127-9

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 61

  1. Del Bigio MR. Neuropathology and structural changes in hydrocephalus. Dev Disabil Res Rev. 2010;16:16–22. · DOI · Paper page
  2. Oi S. Hydrocephalus research update-controversies in definition and classification of hydrocephalus. Neurol Med Chir (Tokyo). 2010;50:859–69. · DOI
  3. Jimenez AJ, Dominguez-Pinos MD, Guerra MM, Fernandez-Llebrez P, Perez-Figares JM. Structure and function of the ependymal barrier and diseases associated with ependyma disruption. Tissue Barriers. 2014;2:e28426. · DOI
  4. Leinonen V, Vanninen R, Rauramaa T. Cerebrospinal fluid circulation and hydrocephalus. Handb Clin Neurol. 2017;145:39–50. · DOI
  5. Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet. 1976;2:924–6. · DOI
  6. Kempton MJ, Stahl D, Williams SC, DeLisi LE. Progressive lateral ventricular enlargement in schizophrenia: a meta-analysis of longitudinal MRI studies. Schizophr Res. 2010;120:54–62. · DOI
  7. Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, et al. Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson’s disease. Neurobiol Aging. 2017;55:78–90. · DOI
  8. Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, et al. Ventricular enlargement as a possible measure of Alzheimer’s disease progression validated using the Alzheimer’s disease neuroimaging initiative database. Brain. 2008;131:2443–54. · DOI · Paper page
  9. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D. Alzheimer’s disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis. Lancet Neurol. 2003;2:506–11. · DOI
  10. Martin-Laez R, Valle-San Roman N, Rodriguez-Rodriguez EM, Marco-de Lucas E, Berciano Blanco JA, Vazquez-Barquero A. Current concepts on the pathophysiology of idiopathic chronic adult hydrocephalus: are we facing another neurodegenerative disease? Neurologia. 2018;33:449–58. · DOI
  11. Reeves BC, Karimy JK, Kundishora AJ, Mestre H, Cerci HM, Matouk C, et al. Glymphatic system impairment in alzheimer’s disease and idiopathic normal pressure hydrocephalus. Trends Mol Med. 2020;26:285–95. · DOI
  12. Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci. 1997;17:171–80. · DOI
  13. Rash JE, Yasumura T, Hudson CS, Agre P, Nielsen S. Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord. Proc Natl Acad Sci U.S.A. 1998;95:11981–6. · DOI
  14. Feng X, Papadopoulos MC, Liu J, Li L, Zhang D, Zhang H, et al. Sporadic obstructive hydrocephalus in Aqp4 null mice. J Neurosci Res. 2009;87:1150–5. · DOI
  15. Bloch O, Auguste KI, Manley GT, Verkman AS. Accelerated progression of kaolin-induced hydrocephalus in aquaporin-4-deficient mice. J Cereb Blood Flow Metab. 2006;26:1527–37. · DOI
  16. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med. 2012;4:147ra111. · DOI · Paper page
  17. Haj-Yasein NN, Vindedal GF, Eilert-Olsen M, Gundersen GA, Skare O, Laake P, et al. Glial-conditional deletion of aquaporin-4 (Aqp4) reduces blood-brain water uptake and confers barrier function on perivascular astrocyte endfeet. Proc Natl Acad Sci U.S.A. 2011;108:17815–20. · DOI
  18. Vindedal GF, Thoren AE, Jensen V, Klungland A, Zhang Y, Holtzman MJ, et al. Removal of aquaporin-4 from glial and ependymal membranes causes brain water accumulation. Mol Cell Neurosci. 2016;77:47–52. · DOI
  19. Papadopoulos MC, Verkman AS. Aquaporin water channels in the nervous system. Nat Rev Neurosci. 2013;14:265–77. · DOI
  20. Nakada T, Kwee IL. Fluid dynamics inside the brain barrier: current concept of interstitial flow, glymphatic flow, and cerebrospinal fluid circulation in the brain. Neuroscientist. 2019;25:155–66. · DOI
  21. Hasan-Olive MM, Enger R, Hansson HA, Nagelhus EA, Eide PK. Loss of perivascular aquaporin-4 in idiopathic normal pressure hydrocephalus. Glia. 2019;67:91–100. · DOI
  22. Wang X, Zhou Y, Wang J, Tseng IC, Huang T, Zhao Y, et al. SNX27 deletion causes hydrocephalus by impairing ependymal cell differentiation and ciliogenesis. J Neurosci. 2016;36:12586–97. · DOI
  23. Steinberg F, Gallon M, Winfield M, Thomas EC, Bell AJ, Heesom KJ, et al. A global analysis of SNX27-retromer assembly and cargo specificity reveals a function in glucose and metal ion transport. Nat Cell Biol. 2013;15:461–71. · DOI · Paper page
  24. Cullen PJ, Steinberg F. To degrade or not to degrade: mechanisms and significance of endocytic recycling. Nat Rev Mol Cell Biol. 2018;19:679–96. · DOI · Paper page
  25. Zhang H, Huang T, Hong Y, Yang W, Zhang X, Luo H, et al. The retromer complex and sorting nexins in neurodegenerative diseases. Front Aging Neurosci. 2018;10:79. · DOI
  26. Iglesias T, Cabrera-Poch N, Mitchell MP, Naven TJ, Rozengurt E, Schiavo G. Identification and cloning of Kidins220, a novel neuronal substrate of protein kinase D. J Biol Chem. 2000;275:40048–56. · DOI
  27. Kong H, Boulter J, Weber JL, Lai C, Chao MV. An evolutionarily conserved transmembrane protein that is a novel downstream target of neurotrophin and ephrin receptors. J Neurosci. 2001;21:176–85. · DOI
  28. Neubrand VE, Cesca F, Benfenati F, Schiavo G. Kidins220/ARMS as a functional mediator of multiple receptor signalling pathways. J Cell Sci. 2012;125:1845–54.
  29. Scholz-Starke J, Cesca F. Stepping out of the shade: control of neuronal activity by the scaffold protein kidins220/ARMS. Front Cell Neurosci. 2016;10:68. · DOI
  30. Lopez-Menendez C, Gamir-Morralla A, Jurado-Arjona J, Higuero AM, Campanero MR, Ferrer I, et al. Kidins220 accumulates with tau in human Alzheimer’s disease and related models: modulation of its calpain-processing by GSK3beta/PP1 imbalance. Hum Mol Genet. 2013;22:466–82. · DOI
  31. Gamir-Morralla A, Lopez-Menendez C, Ayuso-Dolado S, Tejeda GS, Montaner J, Rosell A, et al. Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity. Cell Death Dis. 2015;6:e1939. · DOI
  32. Gamir-Morralla A, Belbin O, Fortea J, Alcolea D, Ferrer I, Lleo A, et al. Kidins220 correlates with Tau in alzheimer’s disease brain and cerebrospinal fluid. J Alzheimers Dis. 2017;55:1327–33. · DOI
  33. Sebastian-Serrano A, Simon-Garcia A, Belmonte-Alfaro A, Pose-Utrilla J, Santos-Galindo M, Del Puerto A, et al. Differential regulation of Kidins220 isoforms in Huntington’s disease. Brain Pathol. 2020;30:120–36. · DOI
  34. Lopez-Benito S, Sanchez-Sanchez J, Brito V, Calvo L, Lisa S, Torres-Valle M, et al. Regulation of BDNF release by ARMS/Kidins220 through modulation of synaptotagmin-IV Levels. J Neurosci. 2018;38:5415–28. · DOI
  35. Kranz TM, Goetz RR, Walsh-Messinger J, Goetz D, Antonius D, Dolgalev I, et al. Rare variants in the neurotrophin signaling pathway implicated in schizophrenia risk. Schizophr Res. 2015;168:421–8. · DOI
  36. Malaspina D, Kranz TM, Heguy A, Harroch S, Mazgaj R, Rothman K, et al. Prefrontal neuronal integrity predicts symptoms and cognition in schizophrenia and is sensitive to genetic heterogeneity. Schizophr Res. 2016;172:94–100. · DOI
  37. Kranz TM, Berns A, Shields J, Rothman K, Walsh-Messinger J, Goetz RR, et al. Phenotypically distinct subtypes of psychosis accompany novel or rare variants in four different signaling genes. EBioMedicine. 2016;6:206–14. · DOI
  38. Josifova DJ, Monroe GR, Tessadori F, de Graaff E, van der Zwaag B, Mehta SG, et al. Heterozygous KIDINS220/ARMS nonsense variants cause spastic paraplegia, intellectual disability, nystagmus, and obesity. Hum Mol Genet. 2016;25:2158–67. · DOI
  39. Mero IL, Mork HH, Sheng Y, Blomhoff A, Opheim GL, Erichsen A, et al. Homozygous KIDINS220 loss-of-function variants in fetuses with cerebral ventriculomegaly and limb contractures. Hum Mol Genet. 2017;26:3792–6. · DOI
  40. Cesca F, Yabe A, Spencer-Dene B, Scholz-Starke J, Medrihan L, Maden CH, et al. Kidins220/ARMS mediates the integration of the neurotrophin and VEGF pathways in the vascular and nervous systems. Cell Death Differ. 2012;19:194–208. · DOI
  41. Cesca F, Yabe A, Spencer-Dene B, Arrigoni A, Al-Qatari M, Henderson D, et al. Kidins220/ARMS is an essential modulator of cardiovascular and nervous system development. Cell Death Dis. 2011;2:e226. · DOI
  42. Lopez-Menendez C, Simon-Garcia A, Gamir-Morralla A, Pose-Utrilla J, Lujan R, Mochizuki N, et al. Excitotoxic targeting of Kidins220 to the Golgi apparatus precedes calpain cleavage of Rap1-activation complexes. Cell Death Dis. 2019;10:535. · DOI
  43. Mirzadeh Z, Doetsch F, Sawamoto K, Wichterle H, Alvarez-Buylla A. The subventricular zone en-face: wholemount staining and ependymal flow. J Vis Exp. 2010; J Vis Exp. 2010; 39:e1938. · DOI
  44. Del Bigio MR. Ependymal cells: biology and pathology. Acta Neuropathol. 2010;119:55–73. · DOI
  45. Roales-Bujan R, Paez P, Guerra M, Rodriguez S, Vio K, Ho-Plagaro A, et al. Astrocytes acquire morphological and functional characteristics of ependymal cells following disruption of ependyma in hydrocephalus. Acta Neuropathol. 2012;124:531–46. · DOI
  46. Raponi E, Agenes F, Delphin C, Assard N, Baudier J, Legraverend C, et al. S100B expression defines a state in which GFAP-expressing cells lose their neural stem cell potential and acquire a more mature developmental stage. Glia. 2007;55:165–77. · DOI
  47. Jacquet BV, Salinas-Mondragon R, Liang H, Therit B, Buie JD, Dykstra M, et al. FoxJ1-dependent gene expression is required for differentiation of radial glia into ependymal cells and a subset of astrocytes in the postnatal brain. Development. 2009;136:4021–31. · DOI
  48. Redmond SA, Figueres-Onate M, Obernier K, Nascimento MA, Parraguez JI, Lopez-Mascaraque L, et al. Development of ependymal and postnatal neural stem cells and their origin from a common embryonic progenitor. Cell Rep. 2019;27:429–41. e423 · DOI
  49. Benfenati V, Caprini M, Dovizio M, Mylonakou MN, Ferroni S, Ottersen OP, et al. An aquaporin-4/transient receptor potential vanilloid 4 (AQP4/TRPV4) complex is essential for cell-volume control in astrocytes. Proc Natl Acad Sci U.S.A. 2011;108:2563–8. · DOI
  50. Madrid R, Le Maout S, Barrault MB, Janvier K, Benichou S, Merot J. Polarized trafficking and surface expression of the AQP4 water channel are coordinated by serial and regulated interactions with different clathrin-adaptor complexes. EMBO J. 2001;20:7008–21. · DOI
  51. Clairfeuille T, Mas C, Chan AS, Yang Z, Tello-Lafoz M, Chandra M, et al. A molecular code for endosomal recycling of phosphorylated cargos by the SNX27-retromer complex. Nat Struct Mol Biol. 2016;23:921–32. · DOI · Paper page
  52. Neely JD, Amiry-Moghaddam M, Ottersen OP, Froehner SC, Agre P, Adams ME. Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein. Proc Natl Acad Sci U.S.A. 2001;98:14108–13. · DOI
  53. Nakahama K, Fujioka A, Nagano M, Satoh S, Furukawa K, Sasaki H, et al. A role of the C-terminus of aquaporin 4 in its membrane expression in cultured astrocytes. Genes Cells. 2002;7:731–41. · DOI
  54. Li X, Kong H, Wu W, Xiao M, Sun X, Hu G. Aquaporin-4 maintains ependymal integrity in adult mice. Neuroscience. 2009;162:67–77. · DOI
  55. Wu KY, Tang FL, Lee D, Zhao Y, Song H, Zhu XJ, et al. Ependymal Vps35 promotes ependymal cell differentiation and survival, suppresses microglial activation, and prevents neonatal hydrocephalus. J Neurosci. 2020;40:3862–79. · DOI
  56. Jaudon F, Chiacchiarettla M, Albini M, Ferroni S, Benfenati F, Cesca F. Kidins220/ARMS controls astrocyte calcium signaling and neuron-astrocyte communication. Cell Death Differ. 2020;27:1505–19. · DOI
  57. Balklava Z, Pant S, Fares H, Grant BD. Genome-wide analysis identifies a general requirement for polarity proteins in endocytic traffic. Nat Cell Biol. 2007;9:1066–73. · DOI
  58. Shinde SR, Maddika S. PTEN regulates glucose transporter recycling by impairing SNX27 retromer assembly. Cell Rep. 2017;21:1655–66. · DOI
  59. Stangl A, Elliott PR, Pinto-Fernandez A, Bonham S, Harrison L, Schaub A, et al. Regulation of the endosomal SNX27-retromer by OTULIN. Nat Commun. 2019;10:4320. · DOI
  60. Ringstad G, Vatnehol SAS, Eide PK. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain. 2017;140:2691–705. · DOI · Paper page
  61. Eide PK, Ringstad G. Delayed clearance of cerebrospinal fluid tracer from entorhinal cortex in idiopathic normal pressure hydrocephalus: a glymphatic magnetic resonance imaging study. J Cereb Blood Flow Metab. 2019;39:1355–68. · DOI

Cited by

Sorted by citations

Metadata

Authors
del Puerto, A., Pose-Utrilla, J., Simón-García, A., López-Menéndez, C., Jiménez, A. J., Porlan, E., Pajuelo, L. S. M., Cano-García, G., Martí-Prado, B., Sebastián-Serrano, Á., Sánchez-Carralero, M. P., Cesca, F., Schiavo, G., Ferrer, I., Fariñas, I., Campanero, M. R., & Iglesias, T.
Venue
Molecular Psychiatry
Published
2021-05-17
Volume
26
Issue
11
Pages
6411-6426
ISSN
  • 1359-4184
  • 1476-5578
Cited by
28
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review